Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
178.6 USD | +0.48% | +1.23% | +44.83% |
06-12 | Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing | MT |
06-12 | Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.83% | 5.08B | |
+16.21% | 122B | |
+19.69% | 113B | |
+3.14% | 22.66B | |
-17.06% | 21.34B | |
-39.57% | 16.92B | |
-14.02% | 16.68B | |
-16.22% | 16.61B | |
+3.21% | 13.62B | |
+21.86% | 11.04B |
- Stock Market
- Equities
- KRYS Stock
- News Krystal Biotech, Inc.
- Chardan Research Adjusts Price Target on Krystal Biotech to $130 From $137, Citing Q2 Results, Spend Forecasts; Buy Rating Kept